(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.14%) $0.928
(0.32%) $10.88
(0.01%) $0.792
(0.01%) $92.59
@ $3.11
Issued: 14 Feb 2024 @ 13:43
Return: -9.32%
Previous signal: Feb 14 - 11:27
Previous signal:
Return: 3.15 %
Live Chart Being Loaded With Signals
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology...
Stats | |
---|---|
Today's Volume | 335 900 |
Average Volume | 1.58M |
Market Cap | 94.84M |
EPS | $0 ( 2024-03-12 ) |
Next earnings date | ( $-0.750 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.460 |
ATR14 | $0.00500 (0.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-14 | Yocca Frank | Buy | 521 | Common Stock |
2023-12-14 | Yocca Frank | Sell | 521 | Restricted Stock Units |
2023-12-14 | Mehta Vimal | Buy | 2 609 | Common Stock |
2023-12-14 | Mehta Vimal | Sell | 2 609 | Restricted Stock Units |
2023-12-14 | Rodriguez Javier | Buy | 521 | Common Stock |
INSIDER POWER |
---|
-11.07 |
Last 81 transactions |
Buy: 351 248 | Sell: 440 033 |
Volume Correlation
BioXcel Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
AGNC | 0.927 |
NWL | 0.905 |
BOCH | 0.904 |
PRAX | 0.896 |
YQ | 0.896 |
SLVO | 0.894 |
GRFS | 0.893 |
SHYF | 0.891 |
CASS | 0.888 |
CLPS | 0.888 |
10 Most Negative Correlations | |
---|---|
CRSA | -0.937 |
LONE | -0.906 |
PPBT | -0.903 |
SNCR | -0.902 |
TSLA | -0.897 |
MVBF | -0.882 |
TLMD | -0.88 |
EPZM | -0.878 |
RMRM | -0.876 |
MTEK | -0.876 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BioXcel Therapeutics Inc Correlation - Currency/Commodity
BioXcel Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $1.38M |
Gross Profit: | $-198 000 (-14.35 %) |
EPS: | $-6.15 |
Q4 | 2023 |
Revenue: | $376 000 |
Gross Profit: | $-416 000 (-110.64 %) |
EPS: | $-0.760 |
Q3 | 2023 |
Revenue: | $341 000 |
Gross Profit: | $-171 000 (-50.15 %) |
EPS: | $-1.720 |
Q2 | 2023 |
Revenue: | $457 000 |
Gross Profit: | $431 000 (94.31 %) |
EPS: | $-1.830 |
Financial Reports:
No articles found.
BioXcel Therapeutics Inc
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators